{"id":72,"date":"2019-07-14T16:26:16","date_gmt":"2019-07-14T16:26:16","guid":{"rendered":"http:\/\/isfcp.org\/isfcp_autonomous\/?page_id=72"},"modified":"2021-08-07T08:30:58","modified_gmt":"2021-08-07T08:30:58","slug":"technologies-transferred","status":"publish","type":"page","link":"https:\/\/isfcp.org\/i\/technologies-transferred\/","title":{"rendered":"Technologies Transferred"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Technologies Transferred<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n
\n

S.No.<\/strong><\/p>\n<\/td>\n

\n

Title<\/strong><\/p>\n<\/td>\n

\n

Description<\/strong><\/p>\n<\/td>\n

\n

Inventer(s)<\/strong><\/p>\n<\/td>\n

\n

Industry Partner<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

1.       <\/p>\n<\/td>\n

\n

MINT ORAL FILMS<\/p>\n<\/td>\n

\n

Formulation and Technology<\/p>\n

Transfer for Mint Oral Films<\/p>\n<\/td>\n

\n

Dr. Gaurav Goyal<\/p>\n

Mr. Ramesh<\/p>\n<\/td>\n

\n

FILGAP INDIA PVT LTD, Mumbai<\/p>\n<\/td>\n<\/tr>\n

\n

2.       <\/p>\n<\/td>\n

\n

TOPICAL NANO FIBROUS OCULAR PATCH<\/p>\n<\/td>\n

\n

Prevention invention relates to nano-ocular patch for the delivery of therapeutic entities via ocular route. Nano-patch of present invention provides comfortable and controlled delivery of encapsulated therapeutics constantly over a period of several months.
<\/p>

KEY FEATURES: 100 % transmittance efficiency, controlled drug delivery, applicable for both topical and intra ocular route.
<\/p>\n<\/td>\n

\n

Shivani, Amit Kumar Goyal and Gautam Rath<\/p>\n<\/td>\n

\n

NRDC, New Delhi<\/p>\n<\/td>\n<\/tr>\n

\n

3.       <\/p>\n<\/td>\n

\n

ULTRA THIN NANO FIBROUS PATCH FOR INSULIN DELIVERY<\/p>\n<\/td>\n

\n

The present invention comprises of nano-trans mucosal patches for sublingual delivery of insulin. The high surface area of volume ratio of the nano-patch provide better mucoadhesion, Controlled drug release and 3D scaffold retain the structure integrity of encapsulated protein and peptides.
<\/p>

KEY FEATURES: Nano-invasive means for insulin delivery, solid unit dosage form, easy to scale-up and produced under aseptic condition.<\/p>\n<\/td>\n

\n

Abhinandan Sharma, Gautam rath, Sanjay dhakate, Amit kumar goyal<\/p>\n<\/td>\n

\n

NRDC, New Delhi<\/p>\n<\/td>\n<\/tr>\n

\n

4.       <\/p>\n<\/td>\n

\n

AN INTEGRATED SPRAY DRYERVICE \u201cPARTICLE FRACTIONATOR\u201d<\/p>\n<\/td>\n

\n

Present innovation provide dynamic solution and opens and new avenue in spray drying technology specially in terms of product yield and particle separation efficacy.
<\/p>

KEY FEATURES: Improved product yield greater energy efficiency compact size, easy to clean and low maintenance.<\/p>\n<\/td>\n

\n

Amit kumar goyal and Gautam rath<\/p>\n<\/td>\n

\n

Labultina Dahisar Mumbai<\/p>\n<\/td>\n<\/tr>\n

\n

5.       <\/p>\n<\/td>\n

\n

SUSTAINED RELEASE FORMULATION OF CARBAMAZEPINE WITH IMPROVED THERAPEUTIC PROFILE AND PRODUCTIVITY<\/p>\n<\/td>\n

\n

Present innovation involves development of a novel sustained release formulation for improved therapeutic profile and higher productivity. Production process was also scaled up and validated as per industrial quality management practices.<\/p>

KEY FEATURES: Better drug release profile, improved efficacy and patient compliance, low cost and high productivity.<\/p>\n<\/td>\n

\n

Nitesh Kapila and Ashish Baldi<\/p>\n<\/td>\n

\n

Consern Pharma pvt. Ltd. ludhiana<\/p>\n<\/td>\n<\/tr>\n

\n

6.       <\/p>\n<\/td>\n

\n

HERBAL SHAVING CREAM<\/p>\n<\/td>\n

\n

Present innovation involves development of a novel sustained release formulation for improved therapeutic profile and higher productivity. Production process was also scaled up and validated as per industrial quality management practices.<\/p>

KEY FEATURES: Better drug release profile, improved efficacy and patient compliance, low cost and high productivity.<\/p>\n<\/td>\n

\n

Amit kumar goyal and Gautam rath<\/p>\n<\/td>\n

\n

Swisskem heathcare, ludhiana<\/p>\n<\/td>\n<\/tr>\n

\n

7.       <\/p>\n<\/td>\n

\n

DEVELOPMENT OF GEMCITABINE LIPOSOMAL INJECTION USING NOVEL LIPIDS<\/p>\n<\/td>\n

\n

Present innovation discloses the composition and methods for liposomes using novel lipids. The formulation provides prolong release of the drug improved therapeutic ratio, lower toxicity, reduced systemic side effects and stability for several months. The formulation is in particular for treatment of solid tumors.
<\/p>

KEY FEATURES: Improved therapeutic efficacy, higher storage stability, easy surface modification.<\/p>\n<\/td>\n

\n

R.S.R Murthy<\/p>\n<\/td>\n

\n

Cosmos research Lab. Ltd. Ludhiana<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Technologies Transferred S.No. Title Description Inventer(s) Industry Partner 1.        MINT ORAL FILMS Formulation and Technology Transfer for Mint Oral Films Dr. Gaurav Goyal Mr. Ramesh FILGAP INDIA PVT LTD, Mumbai 2.        TOPICAL NANO FIBROUS OCULAR PATCH Prevention invention relates to…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"pagelayer_contact_templates":[],"_pagelayer_content":"","footnotes":""},"class_list":["post-72","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/isfcp.org\/i\/wp-json\/wp\/v2\/pages\/72","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isfcp.org\/i\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/isfcp.org\/i\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/isfcp.org\/i\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/isfcp.org\/i\/wp-json\/wp\/v2\/comments?post=72"}],"version-history":[{"count":9,"href":"https:\/\/isfcp.org\/i\/wp-json\/wp\/v2\/pages\/72\/revisions"}],"predecessor-version":[{"id":3604,"href":"https:\/\/isfcp.org\/i\/wp-json\/wp\/v2\/pages\/72\/revisions\/3604"}],"wp:attachment":[{"href":"https:\/\/isfcp.org\/i\/wp-json\/wp\/v2\/media?parent=72"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}